Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended - Net Worth and Insider Trading
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .
Insider Ownership Summary of Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTTX | Better Therapeutics Inc | 2021-10-28 | 10 percent owner |
| MCADU | Mountain Crest Acquisition Corp II | 2021-10-28 | 10 percent owner |
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Trading Performance
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Ownership Network
Ownership Network List of Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Owned Company Details
What does Better Therapeutics Inc do?
Who are the key executives at Better Therapeutics Inc?
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended is the 10 percent owner of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and Chief Medical Officer Mark A. Berman .
Better Therapeutics Inc (BTTX) Insider Trades Summary
Over the past 18 months, Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended made no insider transaction in Better Therapeutics Inc (BTTX). Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 6,202,742 shares made by David P Perry , a net purchase of 988,055 shares made by Geoffrey M. Parker , and a net purchase of 577,040 shares made by Andrew J. Armanino .
In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 8,236,919 shares were bought by its insiders, resulting in a net purchase of 8,236,919 shares.
Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Better Therapeutics Inc Insider Transactions
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended. You might contact Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended via mailing address: 548 Market Street, #49404, San Francisco Ca 94104.
Discussions on Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
